Epitope mapping of cytochrome P4502D6 (CYP2D6) autoantigen in patients with chronic hepatitis C under α-interferon treatment.

被引：0
|
作者：
Dalekos, G [1 ]
Wedemeyer, H [1 ]
Obermayer-Straub, P [1 ]
Kayser, A [1 ]
Barut, A [1 ]
Frank, H [1 ]
Manns, M [1 ]
机构：
[1] Med Hsch Hannover, Dept Gastroenterol & Hepatol, Hannover, Germany
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1384
引用
收藏
页码：508A / 508A
页数：1
相关论文
共 50 条
  • [21] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans (vol 5, pg 173, 2005)
    Gaedigk, A
    Bhathena, A
    Ndjountché, L
    Pearce, RE
    Abdel-Rahman, SM
    Alander, SW
    Bradford, LD
    Leeder, JS
    PHARMACOGENOMICS JOURNAL, 2005, 5 (04): : 276 - 276
  • [22] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Independent commentary
    Brosen, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) : S749 - S750
  • [23] Effect of psychotropic medication on the cytochrome P4502D6 phenotype
    Hartler, S
    Kohler, D
    Fuchs, C
    Sieghart, W
    Hiemke, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 459 - 459
  • [24] Cytochrome P4502D6 gene polymorphism in Chinese population
    Tao, Enxiang
    Liu, Zhuolin
    Chen, Biao
    Pan, Xibang
    Zhonghua Yixue Yichuanxue Zazhi/Chinese Journal of Medical Genetics, 1998, 15 (01): : 34 - 37
  • [25] Cytochrome P4502D6 polymorphism in eastern Indian population
    Dhuya, Monalisa
    Pal, Murari Mohan
    Hazra, Avijit
    Chatterjee, Suparna
    Gogtay, Nithya
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (03) : 189 - 195
  • [26] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Author's commentary
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) : S748 - S749
  • [27] Polymorphism in cytochrome P4502D6 mediated activation of aldicarb in rats
    Silvari, V
    D'Angelo, V
    Catania, S
    Tornqvist, M
    Zahlsen, K
    Costa, C
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 256 - 257
  • [28] Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 17 - 22
  • [29] Identification and characterization of cytochrome P4502D6*56B (CYP2D6*56B), a novel allele associated with the poor metabolizer phenotype.
    Gaedigk, A.
    Eklund, J. D.
    Pearce, R. E.
    Leeder, J. S.
    Alander, S. W.
    Bradford, L. D.
    Kennedy, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S85 - S85
  • [30] A patient with treatment-resistant schizophrenia and cytochrome P4502D6 gene duplication
    Kawanishi, C
    Furuno, T
    Kishida, I
    Matsumura, T
    Kosaka, K
    CLINICAL GENETICS, 2002, 61 (02) : 152 - 154
12345